Validation of an Allergic Rhinitis Control Test in Children

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-11
SponsorUniversity Hospital, Montpellier

About this trial

Allergic rhinitis is a common condition that affects adults as well as children and adolescents, often with impaired quality of life. Patients often report a poor level of satisfaction with the effectiveness of their treatment and are always looking for more drug combinations to improve their symptom. Several tools exist for assessing control of allergic rhinitis, but none has been validated in teenagers or in children. A study conducted in 2008, resulted in the validation of a self-administered control test of allergic rhinitis (ARCT) in patients from 12 years of age. We propose to adapt ARCT adult to pediatric population from 5 to 11 years old.

Eligibility criteria

Qualifiers

Patients aged 5 to 11 years old, consulting a practitioner for an allergic rhinitis

Parents formulated their study participation agreement by signing the consent form.

Disqualifiers

Patients that are already treated for the actual episode of allergic rhinitis and are satisfied of the treatment.

Trial design

Treatments tested in this trial

  • Self Questionnaire

Treatment groups

135 Participants
are divided into 1 treatment group